The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction

Abstract

Ejaculatory dysfunction is not only psychologically distressing but can become a significant obstacle for men who wish to conceive. Dysfunction comes in the form of anejaculation, reduced ejaculation, retrograde ejaculation, painful ejaculation, or premature ejaculation. Most treatments for lower urinary tract symptoms related to benign prostatic hyperplasia, which commonly occurs in aging men, carry significant risks of absent, reduced, or retrograde ejaculation. This review focuses on such risks that accompany both the medical and surgical management of lower urinary tract symptoms/benign prostatic hyperplasia and how these risks impact male fertility.

Keywords: Benign prostatic hyperplasia; HoLEP; TURP; alpha-blocker; aquablation; ejaculation; ejaculatory dysfunction; finasteride; prostatic urethral lift; transurethral resection of prostate; water vapor therapy.